consultant in complex pain/pain transformation, programme clinical lead, NHS Gloucestershire CCG
Dr Cathy Stannard has worked as a Consultant in Pain Medicine for 23 years and is now a Consultant in Complex Pain and Pain Transformation Programme Clinical Lead for NHS Gloucestershire CCG. She has written numerous chapters and four textbooks on aspects of pain management, evidence, and opioid therapy in particular and published widely on the use of opioids for persistent pain and the potential implications of analgesic prescribing for public health. She has chaired working groups for the Medical Royal Colleges, professional organisations and policymakers on Pain and Substance Misuse, Best Practice in Opioid Prescribing, Pain and Addiction and Pain Management in Secure Environments. Dr Stannard is involved in the work of a number of bodies including, PHE, NHS England, MHRA, European Medicines Agency, NICE and the Cochrane collaboration. She is board member of the IASP special interest group on Systematic Reviews and Outcome Evaluation, Member of the IASP International Taskforce on Opioids and group member for the WHO Guideline on Cancer Pain Management. She is currently Clinical lead for the NICE Guideline on Persistent Pain. She has a busy schedule of lectures nationally and internationally on use of opioids and on problem opioid use to policymakers, professionals working in the field of pain and other medical disciplines. She has run multidisciplinary services for patients on high dose opioids and patients with challenging psychiatric co-morbidity. She has recently led a national strategy for improving pain management in prisons and provides in-reach pain services to five prisons in the South West of England. Dr Stannard frequently contributes to conversations about pain, opioids and painkiller addiction in both written and broadcast media.
Speaker at Pulse LIVE London 2018